Cargo Therapeutics Inc Quick Ratio (CRGX) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Cargo Therapeutics Inc   (NASDAQ: CRGX)

Cargo Therapeutics Inc 's Quick Ratio

CRGX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Cargo Therapeutics Inc 's Cash & cash equivalent, this led to improvement in Cargo Therapeutics Inc 's Quick Ratio to 12.08, Quick Ratio remained below Cargo Therapeutics Inc average.

Within Biotechnology & Pharmaceuticals industry 16 other companies have achieved higher Quick Ratio than Cargo Therapeutics Inc in second quarter 2025. While Quick Ratio total ranking has improved so far during the Q2 2025 to 216, from total ranking in the first quarter 2025 at 391.

Explain Quick Ratio?
How much Cash & cash equivalents CRGX´s has?
What are CRGX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRGX Quick Ratio (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2
Y / Y Current Liabilities Change -20.87 % 127.61 % 18.26 % -47.39 % -12.13 %
Y / Y Cash & cash equivalent Change -43.05 % -15.18 % -16.27 % 570.9 % 23590.06 %
Quick Ratio MRQ 12.08 6.18 13.57 18.71 16.78
CRGX's Total Ranking # 216 # 391 # 123 # 86 # 161
Seq. Current Liabilities Change -59.44 % 105.99 % 15.64 % -18.1 % 16.67 %
Seq. Cash & cash equivalent Change -20.78 % -6.14 % -16.09 % -8.71 % 17.97 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 102
Overall Market # 216


Quick Ratio Statistics
High Average Low
19.17 13.07 1.47
(Dec 31 2023)   (Sep 30 2023)




Financial Statements
Cargo Therapeutics Inc 's Current Liabilities $ 21 Millions Visit CRGX's Balance sheet
Cargo Therapeutics Inc 's Cash & cash equivalent $ 253 Millions Visit CRGX's Balance sheet
Source of CRGX's Sales Visit CRGX's Sales by Geography


Cumulative Cargo Therapeutics Inc 's Quick Ratio

CRGX's Quick Ratio for the trailling 12 Months

CRGX Quick Ratio

 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 6.97 % 8.37 % 3.66 % 29.03 % 270.37 %
Y / Y Cash & cash equivalent TTM Growth 2.37 % 78.57 % 234.21 % 2519.86 % 68568.11 %
Quick Ratio TTM 11.05 12.09 16.33 17.74 11.54
Total Ranking TTM # 3242 # 2678 # 1717 # 1865 # 2787
Seq. Current Liabilities TTM Growth -4.43 % 30.19 % 4.21 % -17.5 % -3.17 %
Seq. Cash & cash equivalent TTM Growth -12.67 % -3.65 % -4.05 % 26.8 % 52.33 %

Quick ratio ranking by company, industry and sector >> Back to CRGX Financial Strength Comparisons >> Go to Compare CRGX Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CRGX's Current Liabilities to $20.91 millions, cumulative Quick Ratio to 11.05 below the CRGX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 153 other companies have achieved higher Quick Ratio than Cargo Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 2678 to 3242.

Explain Quick Ratio?
How much Cash & cash equivalents CRGX´s has?
What are CRGX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 154
Healthcare Sector # 885
Within the Market # 3242


trailing twelve months Quick Ratio Statistics
High Average Low
17.74 13.75 11.05
(Sep 30 2024)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Tarsus Pharmaceuticals Inc   32.82 $ 381.143  Millions$ 11.612  Millions
Voyager Therapeutics Inc   31.36 $ 433.653  Millions$ 13.829  Millions
Hillevax Inc   25.96 $ 159.547  Millions$ 6.147  Millions
Tectonic Therapeutic Inc   25.30 $ 287.381  Millions$ 11.361  Millions
Tourmaline Bio Inc   24.04 $ 239.234  Millions$ 9.950  Millions
Cg Oncology Inc   21.76 $ 661.052  Millions$ 30.381  Millions
Artiva Biotherapeutics Inc   20.19 $ 142.400  Millions$ 7.053  Millions
Kymera Therapeutics Inc   19.64 $ 665.445  Millions$ 33.874  Millions
Crispr Therapeutics Ag  16.49 $ 1,721.237  Millions$ 104.362  Millions
Apogee Therapeutics Inc   16.02 $ 505.420  Millions$ 31.551  Millions
Cidara Therapeutics Inc   15.80 $ 510.575  Millions$ 32.318  Millions
Qiagen N v   15.12 $ 1,098.918  Millions$ 72.656  Millions
Inhibikase Therapeutics Inc   14.89 $ 87.666  Millions$ 5.887  Millions
Maze Therapeutics Inc   13.29 $ 264.541  Millions$ 19.900  Millions
Genenta Science S p a   13.29 $ 31.527  Millions$ 2.372  Millions
Imagenebio Inc   13.06 $ 95.642  Millions$ 7.324  Millions
In8bio Inc   13.04 $ 13.226  Millions$ 1.014  Millions
Pharmacyte Biotech Inc   12.67 $ 13.440  Millions$ 1.061  Millions
Protara Therapeutics Inc  12.52 $ 122.216  Millions$ 9.761  Millions
Taysha Gene Therapies Inc   12.34 $ 312.761  Millions$ 25.349  Millions
Cargo Therapeutics Inc   12.08 $ 252.567  Millions$ 20.908  Millions
Aura Biosciences Inc   11.94 $ 177.311  Millions$ 14.852  Millions
Kalaris Therapeutics Inc   11.56 $ 88.426  Millions$ 7.651  Millions
Entera Bio Ltd   11.28 $ 10.858  Millions$ 0.963  Millions
Prokidney Corp   10.77 $ 294.728  Millions$ 27.359  Millions
Engene Therapeutics Inc   10.68 $ 201.913  Millions$ 18.913  Millions
Titan Pharmaceuticals Inc   10.66 $ 2.803  Millions$ 0.263  Millions
Century Therapeutics inc   10.43 $ 155.843  Millions$ 14.948  Millions
Acumen Pharmaceuticals Inc   10.42 $ 143.369  Millions$ 13.753  Millions
Neumora Therapeutics Inc   10.41 $ 217.588  Millions$ 20.897  Millions

Date modified: 2026-08-29T17:48:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.